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MEETING PROCEEDINGSThe annual meeting for the Society of Vascular Surgery
(SVS) took place June 11 to 14, 2009, in Denver, Colorado.
A highlight of the meeting was the presidential address of G.
Patrick Clagett, who raised the question: ‘‘Does Vascular
Surgery Cost Too Much?’’ He reviewed the staggering
cost of healthcare in our country and stressed that the rate
of growth in healthcare expenditures is not sustainable and
that the huge disparity in healthcare spending among a vari-
ety of industrialized nations has not translated into better
healthcare outcomes. Dr Clagett described the unusual par-
adox that higher healthcare spending has often been associ-
ated with lower quality of care and slightly worse outcomes.
He went on to say that a significant proportion of President
Obama’s $1.1 billion economic stimulus package has gone
to the National Institutes of Health, Agency for Healthcare
Research and Quality, and Department of Health and Human
Services, specifically for comparative effectiveness research
(CER). Although not specifically stated, CER will have clear
economic implications, and it is hoped that these programs
will reduce variation in practice and save money. Dr Clagett
stressed that the SVS has been active in CER through its
Practice Guidelines and Reporting Standards Committees.
The SVS Vascular Registry has also been an important con-
tribution. Finally, Dr Clagett charged the members of the
SVS to be more actively involved in CER. He cited that of
all specialty groups managing peripheral vascular disease,
we are the most unbiased because we are able to offer all
treatment modalities, and are thus best positioned to offer
high-quality CER. He concluded by stating, ‘‘Finally, these
mandates are clearly spelled out in our mission statement.
Integrity is our middle name. This is the right thing to do
for our membership, for our patients, and for the public.’’
K. Wayne Johnston, MD, from Toronto, was presented
the SVS Lifetime Achievement award.
Among his many outstanding contributions were his term
as president of the SVS from 2007 to 2008 and his role as
Editor-in-Chief of the Journal of Vascular Surgery.
CAROTID ARTERY OCCLUSIVE DISEASE
White and colleagues,1 from the SVS Outcomes Commit-
tee, reported the results from the SVS Vascular Registry,
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doi:10.1016/j.jtcvs.2009.07.057The Journal of Thoracic and Cafocusing on the comparison of carotid artery stenting for ath-
erosclerotic carotid artery disease versus nonatherosclerotic
carotid artery disease. This is a large, voluntary, self-reported
registry. Of 4017 patients with carotid artery stents who are
listed in the registry, 72% were treated for atherosclerosis
and 28% were treated for nonatherosclerosis, including
restenosis (76%), radiation-induced disease (16%), and
others (8%). Patients with atherosclerosis were older and
more often male, and had a higher incidence of coronary
disease, previous myocardial infarction, and other comorbid-
ities. Patients without atherosclerosis had a higher incidence
of amaurosis fugax, smoking, and cancer history. Between
the 2 groups, there were no statistically significant differ-
ences in the rate of death, stroke, or myocardial infarction
at 30 days (3.03% for the atherosclerosis group vs 2.72%
for the nonatherosclerosis group). There were also no differ-
ences in outcomes based on gender or symptomatic status.
The authors concluded that although patients with athero-
sclerosis appeared to be sicker because of additional comor-
bidities, they did not have poor outcomes compared with
patients without atherosclerosis when treated with carotid
artery stenting.
Schor and coworkers,2 from the University of Medicine
and Dentistry of New Jersey in Newark, studied the impact
of prior cervical irradiation on carotid artery stenting. They
reviewed the results of 37 patients who underwent carotid
artery stenting after a history of cervical irradiation. They
compared these patients with a larger cohort without previ-
ous radiation. The patients did not differ with respect to
age, gender, smoking status, or symptoms. Radiated patients
had a lower incidence of hypertension, diabetes, and coro-
nary disease. The 30-day stroke, death, or myocardial infarc-
tion rate was similar in both groups (5.4% of irradiated
patients vs 5.9% of nonirradiated patients). In-stent resteno-
sis in follow-up, however, was higher in patients after radi-
ation therapy at 76% versus 21.6% (P¼ .01). Some 18.9%
of radiated patients required an additional intervention ver-
sus 4.7% of nonirradiated patients (P ¼ .002). The authors
concluded that although periprocedural complications were
not increased for carotid artery stenting in patients with prior
cervical radiation, the durability of carotid artery stenting
was impaired and the need for additional revascularization
procedure was increased in these patients.
AbuRahma and associates,3 from Charleston, West Vir-
ginia, studied the outcomes of primary carotid stenting ver-
sus stenting for recurrent carotid stenosis after previous
endarterectomy. Of 180 patients in the study, 68 had primary
carotid artery stents versus 112 after a previous carotid end-
arterectomy. Clinical characteristics were comparable be-
tween the 2 groups, and follow-up averaged 25 months.rdiovascular Surgery c Volume 138, Number 5 1257
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tive stroke, death, and myocardial infarction rates were
7.4% for the primary group versus 0.9% for the recurrent
carotid stenosis group (P ¼ .03). Stroke-free rates remained
significantly different up to 4 years. Freedom from in-stent
restenosis was high in both groups. The authors concluded
that carotid artery stenting was safer for restenotic lesions
than primary carotid artery plaques.
ABDOMINAL AORTIC ANEURYSMS
Lederle and colleagues4 reported the 2-year results of
the highly anticipated OVER trial. This Veterans Adminis-
tration Hospital-based trial randomized 881 patients (99.3%
were male) to open versus endovascular aneurysm repair
(EVAR) (with any Food and Drug Administration-approved
device) of infrarenal aortic aneurysms over a 9-year period.
Mortality was the primary end point. Thirty-day mortality
was low in both groups but significantly less in the EVAR
group (0.2% vs 2.3%; P ¼ .006). Mortality at 2 years fol-
low-up did not differ (EVAR 7% vs open 9.4%; P ¼ .19).
Major morbidity at 1 year did not differ (EVAR 4.4% vs
open 4.3%). Quality of life and erectile dysfunction did not
differ between the groups. The authors pointed out that the
mortality reported in this trial is lower than in previous ran-
domized trials. Although there was a perioperative survival
advantage with EVAR, it was not sustained in follow-up.
Greenberg and colleagues5 reported the intermediate re-
sults of a US multicenter trial of fenestrated endograft repair
for juxtarenal abdominal aortic aneurysms. These fenestrated
grafts and applied technologies are of obvious interest and
import for thoracic endovascular grafting involving the aortic
arch. Six centers enrolled 30 patients with juxtarenal aneu-
rysms with short proximal necks, which would preclude con-
ventional endovascular repair. A total of 77 visceral vessels
were accommodated by fenestrations in these 30 patients.
The most common designs accommodated 2 renal arteries
and a superior mesenteric artery (66.7%). All endografts
were successfully implanted without the acute loss of any
visceral arteries. Twenty-three of the patients were available
for a 24-month follow-up. There were no aneurysm-related
deaths, ruptures, or conversions to open procedures through-
out 24 months. There were no type 1 or 3 endoleaks observed
at any time point. There were no cases of aneurysm growth
greater than 5 mm in diameter. Eight patients experienced
some form of renal event, including 4 renal artery stenoses,
2 renal artery occlusions, and 2 renal infarcts. Among these
patients, 5 underwent secondary interventions. No patient re-
quired dialysis for renal failure. The authors concluded that
fenestrated endovascular grafts are feasible in centers with
extensive experience in EVAR. They were encouraged that
the results achieved were concordant with other studies re-
ported from single centers of excellence.
Beck and associates6 presented a series of 18 patients
from Athens, Greece, who were treated with fenestrated1258 The Journal of Thoracic and Cardiovascular Suand branched endografts for repair of juxtarenal and parare-
nal abdominal aortic aneurysms after previous open infrare-
nal aortic aneurysm repair. The mean time from the previous
operation was 8.5 years. The mean number of fenestrations
per patient was 3. All patients but 1 were treated completely
by endovascular surgery. The mean operative time was 215
minutes, with a blood loss of 560 mL. Perioperative compli-
cations occurred in 2 patients. After a follow-up of 23
months, the cumulative primary patency was 95% (53/56
vessels). The authors concluded that endovascular treatment
of juxtarenal and pararenal aneurysms after previous aortic
reconstruction is a viable alternative to open repair with
a high success rate and low reintervention rate.
Mehta and associates,7 from Albany Medical College,
studied the implications of endoleaks on aneurysm sac pres-
sure after endovascular repair of elective and ruptured aortic
aneurysms. They reported a series of 480 patients who under-
went infrarenal EVAR with placement of the CardioMEMS
Endosure wireless pressure sensor within the excluded aneu-
rysm sac. The authors documented (CardioMEMS, Atlanta,
Ga) that in patients with type 2 endoleaks (102, 21%), there
were marked elevations of all pressures compared with pa-
tients with no endoleaks. Treatment of type 2 endoleaks
led to a reduction in these pressure indices to those of patients
without endoleaks. Patients with type 1 endoleaks had signif-
icant elevations of pressures that approximated pre-exclusion
aneurysm sac pressures. Similarly, these pressures decreased
significantly after the treatment of type 1 endoleaks. The
authors concluded the presence of type 1 and 2 endoleaks
can be predicted by the evaluation and follow-up of aortic
aneurysm sac pressures. Successful treatment of endoleaks
can be predicted by normalization of these sac pressures.
THORACIC ENDOVASCULAR STENT GRAFTING
Rakhlin and colleagues,8 from the University of Pennsyl-
vania, reported on the use of thoracic endovascular stents in
the management of acute complicated type B dissections and
compared the results in patients with malperfusion syndrome
versus rupture. From 2004 to 2008, 43 patients with acute
complicated type B dissections underwent thoracic endo-
vascular stent grafting and were included in this evaluation.
Twenty-six patients (60%) presented with malperfusion,
22 patients (51%) presented with rupture, and 5 patients
(11%) presented with both. In those with malperfusion, renal
malperfusion occurred in 17 patients (65%), visceral malper-
fusion occurred in 17 patients (65%), and lower extremity
malperfusion occurred in 14 patients (54%). The average pa-
tient follow-up was 16 months. Excellent technical and clin-
ical results were achieved in both groups. Patients who were
treated for rupture presented and were treated earlier. Endog-
raft use and deployment were comparable between the 2
groups. One-year survival was 94% in both groups. Thoracic
endovascular grafting alone was effective in treating aortic
rupture in 21 patients (95%), whereas only 15 patientsrgery c November 2009
Belkin Meeting Proceedings(58%) in the malperfusion group could be completely treated
with stent grafting. Eleven patients (42%) in the malperfu-
sion group required an adjunctive procedure (almost all en-
dovascular) to restore end-organ perfusion. The authors
stressed that although both malperfusion and rupture compli-
cating type B aortic dissections can be successfully treated
with thoracic endografting, the treatment must be customized
to each patient’s presentation to achieve these results.
Mousa and colleagues,9 of the University of Medicine and
Dentistry of New Jersey, New Brunswick, used the National
Inpatient Sample database to evaluate the outcomes and hos-
pital use of thoracic endovascular aneurysm repair (TEVAR)
versus open thoracic repair in the management of acute aortic
trauma. By using the National Inpatient Sample from 2005 to
2006, they identified 1561 patients with thoracic aortic in-
jury; 480 patients underwent emergency surgical interven-
tion, with 245 patients being treated with open thoracic
repair and 235 patients being treated with TEVAR. Mortality
after open repair was significantly greater (14.32%) than
after TEVAR (8.52%; P ¼ .046). Patients treated with
open repair were 2.2 times likely to have pulmonary compli-
cations. After adjustment for age, gender, and comorbidities,
mortality after open repair was greater (odd ratio¼ 2.9; 95%
confidence interval, 1.42–5.75) than after TEVAR. Length of
stay after open repair was significantly longer at 23.8 days
versus 13.5 days (P ¼ .0029) for TEVAR. Open repair was
significantly more expensive than TEVAR ($83,027 vs
$57,092; P ¼ .0214). The authors concluded that the imple-
mentation of TEVAR has been associated with an increasing
number of patients receiving intervention for traumatic aortic
injury along with decreased mortality and resource use. Fur-
ther implementation of TEVAR for aortic trauma may
improve future outcomes and reduce hospitalization use.
Tefera and colleagues,10 from the University of Wiscon-
sin, presented a further comparison on hospital cost and clin-
ical outcomes for open versus endovascular thoracic aortic
aneurysm repair in a single-center study. From November
2006 to May 2008, 60 patients underwent repair of thoracic
aortic aneurysms with either open surgery (35) or TEVAR
(25). An average of 1.8 stent grafts were used per patient.
Morbidity and mortality were similar in both groups. There
was 1 case of paraparesis in the TEVAR group and 1 death in
the open surgical group. Five secondary interventions were
performed for type 1 endoleaks after TEVAR. Hospital stay
was significantly shorter and the nursing cost was lower for
the TEVAR group. Total hospital cost and operating cost
were significantly higher for the TEVAR group. The net
margin was significantly negative for the TEVAR group at
a loss of $20,222 per case. In their discussion, the authors
raised the question as to whether the increased cost associ-
ated with TEVAR could be justified if major advantages in
terms of morbidity and mortality cannot be documented.
Bismuth and coworkers11 from Methodist Debakey Heart
and Vascular Center, Houston, reported the results of a seriesThe Journal of Thoracic and Caof 20 patients who were monitored with transcranial Doppler
during endovascular repair of the thoracic aorta.11 The high-
est number of cerebral microembolic signals occurred with
pigtail catheter placement during the diagnostic stage and
by device placement during the deployment stage. During
the diagnostic stage, an average of 8.6 microembolic signals
occurred, whereas during the deployment stage, 45 right in-
tracranial signals and 43 left intracranial signals occurred.
There was no correlation between the number of microem-
bolic signals and postoperative stroke, transient ischemic at-
tack, arch type, landing zone, or coverage of the subclavian
artery. The authors concluded that transcranial Doppler may
prove to be an important adjunct in thoracic endografting to
identify which steps and procedures are most likely to pro-
voke emboli and to compare endografts and their capacity
to generate microemboli.
Shah and associates,12 from New York University, stud-
ied the results of thoracic endovascular grafting in female
patients. TEVAR was performed in 51 patients (29 female,
56%) for a variety of aortic pathologies. The thoracic aortic
diameter was larger in women than in men (59 vs 47 mm).
TEVAR was more likely to be performed on an urgent basis
in women compared with men. Women were more likely to
require a common iliac artery conduit compared with men
(48.3% vs 20%, P< .05). There was a trend toward an in-
creased paraplegia rate in women (10.3% vs 4.8%). The au-
thors thought this might be related to an increase in total
length of aortic coverage in women compared with men
(18.2 vs 15.2 cm, P< .05). The authors concluded that pro-
phylactic measures to prevent spinal ischemia should be
considered and that the length of coverage should be mini-
mized in female patients.
Pisimisis and colleagues13 presented a 2-institution eval-
uation on the incidence and risk factors of renal dysfunction
after thoracic endovascular aortic repair. Between 1998 and
2008, 175 patients underwent 210 TEVAR procedures for
various aortic pathologies at 2 tertiary institutions. Aortic
pathologies included 103 aneurysms, 72 dissections, 21
transections, and 14 penetrating ulcers. Mean patient age
was 70 years, with a median preoperative estimated glomer-
ular filtration rate (eGFR) of 65 mL/min/1.73 m2. Average
procedural contrast load was 108.7  70 mL. Median
eGFR at 24 hours and 30 days was 69 mL/min/1.73 m2
and 67 mL/min/1.73 m2, respectively. The rates of acute
renal injury, acute renal failure, and hemodialysis were
15.7%, 3.1%, and 0.5%, respectively. Risk factors associ-
ated with a decrease in eGFR at 24 hours were procedural
blood loss, packed red blood cell transfusion, lengthy proce-
dures, open surgical conversion, and several stents de-
ployed. At 1 month, prognostic factors included increasing
age, preoperative rupture, infrarenal abdominal aortic aneu-
rysm, zone 0–2 deployment, larger proximal neck diameter,
and shorter intensive care unit and hospital stays. Factors
that proved to be protective of renal function were obesity,rdiovascular Surgery c Volume 138, Number 5 1259
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namic course. The authors noted in their discussion that
the incidence of renal failure in this cohort was lower than
that compared with previous smaller series. They attributed
this in part to the routine use of intravascular ultrasound dur-
ing the procedure and reduced contrast load.
OPEN REPAIR OF THORACIC AND
THORACOABDOMINAL ANEURYSMS
To provide a contemporary view of the results of open re-
pair of thoracoabdominal aortic aneurysms in the United
States, Oderich and colleagues,14 from The Mayo Clinic,
queried the results from the National Inpatient Sample for
open non-urgent repair of thoracoabdominal aortic aneu-
rysms from 2000 to 2006. A total of 5776 open repairs
were identified during the 7-year period. The median age
was 70 years, and 43% of the patients were women. Major
comorbidities included hypertension (56%), chronic pulmo-
nary disease (35%), chronic renal insufficiency (11%), and
prior myocardial infarction (8%). Postoperative in-house
mortality was significant at 16%. Postoperative complica-
tions included acute renal failure (25%), pulmonary compli-
cations (10%), mesenteric ischemia (3%), and myocardial
infarction (3%). Acute renal failure was the main predictor
of in-hospital mortality, with an odds ratio of 3.5. Indepen-
dent factors associated with postoperative acute renal failure
were increased age, patient comorbidity index, chronic renal
insufficiency, and surgery in a rural or nonteaching hospital.
The authors concluded that open surgical repair of thoracic
aortic aneurysms continues to carry a high postoperative
mortality. They believe the data presented serves as an im-
portant benchmark against which new endovascular and
hybrid approaches can be compared for the treatment of
thoracic aortic aneurysms.
The group from the University of Texas Health Science
Center gave a number of presentations and posters on various
aspects of open thoracic and thoracic aortic aneurysm repair.
One such presentation was by Miller and colleagues,15 who
focused on respiratory morbidity after thoracic aortic aneu-
rysm repair. Between 1991 and 2008, 1443 descending tho-
racic or thoracic aortic aneurysms were repaired with open
surgery. The mean age of patients was 68 years, and 37%
were female. A total of 432 patients (30%) required mechan-
ical ventilation more than 72 hours after surgery. Significant
risk factors for prolonged mechanical ventilation included
a preoperative forced expiratory volume at 1 second less
than 80% of predicted, a decreased GFR, emergency presen-
tation, rupture, and chronic obstructive pulmonary disease.
The only intraoperative variable associated with prolonged
mechanical ventilation was prolonged aortic crossclamp
time. Mortality among patients with prolonged ventilation
was 31% versus 10% of those patients without prolonged
ventilation. The authors concluded that ventilator failure af-
ter open thoracic surgery occurs predominantly in high-risk1260 The Journal of Thoracic and Cardiovascular Supatients with poor preoperative pulmonary and renal func-
tion, as well as those presenting for urgent procedures. Mor-
tality is significantly increased in these patients. Estrera and
colleagues16 presented an additional poster from this group
examining the factors predictive of neurologic deficit and
mortality in contemporary practice. Immediate neurologic
deficits occurred postoperatively in 37 of 1443 patients
(2.5%). Significant predictors were type 2 thoracoabdominal
aortic aneurysms and decreased preoperative eGFR. The use
of cerebrospinal fluid drainage and distal aortic perfusion as
an adjunct reduced neurologic morbidity by two thirds (odds
ratio 0.33, P<.002). Significant predictors of mortality were
decreased eGFR, preoperative rupture, peripheral vascular
disease, coronary artery disease, and type 2 or 3 aortic aneu-
rysm repairs. Miller and colleagues17 examined 1067 of 1443
patients who had distal aortic perfusion during thoracoabdo-
minal aortic aneurysm repair. The authors noted that in
September of 2006, they adopted a side-arm femoral cannu-
lation technique as opposed to a direct femoral cannulation in
an effort to eliminate leg ischemia during cannulation time.
Their hypothesis is that leg ischemia contributes to decreased
renal function postoperatively. The authors demonstrated
that side-arm cannulation was associated with an approxi-
mate 50% reduction in peak postoperative creatinine in pa-
tients with a preoperative GFR less than 70 mL/min/1.73 m2.
The authors concluded that side-arm cannulation was associ-
ated with a clinically important and statistically significant
reduction in postoperative creatinine levels in patients with
low preoperative GFRs. They hypothesized that reduced
skeletal muscle ischemia is the likely mechanism.
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